FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2322822079> ?p ?o ?g. }

• W2322822079 endingPage "187" @default.
• W2322822079 startingPage "179" @default.
• W2322822079 abstract "Objectives Growing evidence supports the role played by inflammation in atherosclerosis. Identifying sensitive biomarkers is useful in predicting accelerated atherosclerosis. We investigated prospectively the relationship between plasma levels of inflammatory biomarkers [osteopontin, C-reactive protein (CRP), interleukin-6 (IL-6)] and instent restenosis, and rapid coronary plaque progression in patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI). Methods We studied 77 patients with CAD: 45 affected by unstable angina/non-ST elevation myocardial infarction [acute coronary syndrome (ACS)], and 32 by chronic coronary syndrome (CCS). Plasma osteopontin, IL-6, and CRP levels were measured before intervention in all patients; measurements were carried out on the basis of the following time course at 1,15, 30, 90, and 180 days follow-up in a subgroup of 39 consenting patients. Clinical and biohumoral data were correlated with baseline and 6-month PCI follow-up angiography. Results Osteopontin, IL-6, and CRP were higher in patients with ACS than in those with CCS (analysis of variance: P<0.001, 0.05, and 0.05, respectively). Baseline osteopontin levels proved to be associated with rapid coronary plaque progression (P=0.005) and instent restenosis (P=0.05). The highest osteopontin levels were found in patients with CAD with both rapid plaque progression and instent restenosis (P=0.003). PCI increased inflammatory markers acutely, and osteopontin remained elevated in patients with ACS. Patients with ACS showed a higher percentage (74%) of rapid plaque progression than those with CCS (26%) (P<0.05). Conclusion The study prospectively shows the link between inflammatory status and accelerated atherosclerosis in patients with CAD undergoing PCI. The baseline and persistent rise of osteopontin is an expression of its contribution to the accelerated plaque progression, and therefore osteopontin may be a useful prognostic biomarker." @default.
• W2322822079 created "2016-06-24" @default.
• W2322822079 creator A5005268552 @default.
• W2322822079 creator A5012099531 @default.
• W2322822079 creator A5017175585 @default.
• W2322822079 creator A5024321702 @default.
• W2322822079 creator A5025184410 @default.
• W2322822079 creator A5032351516 @default.
• W2322822079 creator A5053056134 @default.
• W2322822079 creator A5053858541 @default.
• W2322822079 creator A5068313301 @default.
• W2322822079 creator A5085524023 @default.
• W2322822079 creator A5091897830 @default.
• W2322822079 date "2011-05-01" @default.
• W2322822079 modified "2023-09-29" @default.
• W2322822079 title "Osteopontin plasma levels and accelerated atherosclerosis in patients with CAD undergoing PCI" @default.
• W2322822079 cites W1901628168 @default.
• W2322822079 cites W1975149587 @default.
• W2322822079 cites W1985535636 @default.
• W2322822079 cites W2006993039 @default.
• W2322822079 cites W2011152535 @default.
• W2322822079 cites W2016814134 @default.
• W2322822079 cites W2026803942 @default.
• W2322822079 cites W2038735449 @default.
• W2322822079 cites W2039093757 @default.
• W2322822079 cites W2055638734 @default.
• W2322822079 cites W2064753214 @default.
• W2322822079 cites W2068698868 @default.
• W2322822079 cites W2069378726 @default.
• W2322822079 cites W2073485308 @default.
• W2322822079 cites W2073862130 @default.
• W2322822079 cites W2085263139 @default.
• W2322822079 cites W2088987957 @default.
• W2322822079 cites W2090440262 @default.
• W2322822079 cites W2105632743 @default.
• W2322822079 cites W2109946756 @default.
• W2322822079 cites W2116381107 @default.
• W2322822079 cites W2125283933 @default.
• W2322822079 cites W2134050709 @default.
• W2322822079 cites W2142115385 @default.
• W2322822079 cites W2158336299 @default.
• W2322822079 cites W2164822093 @default.
• W2322822079 cites W2165916469 @default.
• W2322822079 cites W2324841714 @default.
• W2322822079 cites W82493482 @default.
• W2322822079 doi "https://doi.org/10.1097/mca.0b013e3283441d0b" @default.
• W2322822079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21407077" @default.
• W2322822079 hasPublicationYear "2011" @default.
• W2322822079 type Work @default.
• W2322822079 sameAs 2322822079 @default.
• W2322822079 citedByCount "32" @default.
• W2322822079 countsByYear W23228220792012 @default.
• W2322822079 countsByYear W23228220792013 @default.
• W2322822079 countsByYear W23228220792014 @default.
• W2322822079 countsByYear W23228220792015 @default.
• W2322822079 countsByYear W23228220792016 @default.
• W2322822079 countsByYear W23228220792018 @default.
• W2322822079 countsByYear W23228220792019 @default.
• W2322822079 countsByYear W23228220792020 @default.
• W2322822079 countsByYear W23228220792021 @default.
• W2322822079 countsByYear W23228220792022 @default.
• W2322822079 countsByYear W23228220792023 @default.
• W2322822079 crossrefType "journal-article" @default.
• W2322822079 hasAuthorship W2322822079A5005268552 @default.
• W2322822079 hasAuthorship W2322822079A5012099531 @default.
• W2322822079 hasAuthorship W2322822079A5017175585 @default.
• W2322822079 hasAuthorship W2322822079A5024321702 @default.
• W2322822079 hasAuthorship W2322822079A5025184410 @default.
• W2322822079 hasAuthorship W2322822079A5032351516 @default.
• W2322822079 hasAuthorship W2322822079A5053056134 @default.
• W2322822079 hasAuthorship W2322822079A5053858541 @default.
• W2322822079 hasAuthorship W2322822079A5068313301 @default.
• W2322822079 hasAuthorship W2322822079A5085524023 @default.
• W2322822079 hasAuthorship W2322822079A5091897830 @default.
• W2322822079 hasConcept C126322002 @default.
• W2322822079 hasConcept C164705383 @default.
• W2322822079 hasConcept C2777698277 @default.
• W2322822079 hasConcept C2777785093 @default.
• W2322822079 hasConcept C2778213512 @default.
• W2322822079 hasConcept C2778283817 @default.
• W2322822079 hasConcept C2778583881 @default.
• W2322822079 hasConcept C2780400711 @default.
• W2322822079 hasConcept C2780804394 @default.
• W2322822079 hasConcept C45393284 @default.
• W2322822079 hasConcept C500558357 @default.
• W2322822079 hasConcept C71924100 @default.
• W2322822079 hasConceptScore W2322822079C126322002 @default.
• W2322822079 hasConceptScore W2322822079C164705383 @default.
• W2322822079 hasConceptScore W2322822079C2777698277 @default.
• W2322822079 hasConceptScore W2322822079C2777785093 @default.
• W2322822079 hasConceptScore W2322822079C2778213512 @default.
• W2322822079 hasConceptScore W2322822079C2778283817 @default.
• W2322822079 hasConceptScore W2322822079C2778583881 @default.
• W2322822079 hasConceptScore W2322822079C2780400711 @default.
• W2322822079 hasConceptScore W2322822079C2780804394 @default.
• W2322822079 hasConceptScore W2322822079C45393284 @default.
• W2322822079 hasConceptScore W2322822079C500558357 @default.
• W2322822079 hasConceptScore W2322822079C71924100 @default.

• next